Clinical Trials Browser

INDUSTRY × Colorectal Neoplasms × Octreotide × Clear all

NCT00006269 2012-05-25

Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer

Phase 3 Terminated

Gastrointestinal

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms

NCT00050635 2009-11-19

STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea

Phase 4 Completed

Gastrointestinal

Diarrhea, Neoplasms, Colorectal Neoplasms